1x10^6 human PBMCs were surface stained with 0.2 ug Anti-Human CD314 (65188-1-Ig, Clone:1D11) or Mouse IgG1 Isotype Control and CoraLite®647-conjugated AffiniPure F(ab')2 Fragment Goat Anti-Mouse IgG (H+L) (SA00014-8) at dilution 1:1000. Cells were then stained with CL488-conjugated CD8 (CL488-65135). Cells were not fixed. Lymphocytes were gated.
1x10^6 human PBMCs were surface stained with 0.2 ug Anti-Human CD314 (65188-1-Ig, Clone:1D11) or Mouse IgG1 Isotype Control and CoraLite®647-conjugated AffiniPure F(ab')2 Fragment Goat Anti-Mouse IgG (H+L) (SA00014-8) at dilution 1:1000. Cells were not fixed. Lymphocytes were gated.
1X10^6 human PBMCs were surface co-stained with CL488 Anti-Human CD8a (CL488-65204, Clone: UCHT4) and 10 ul APC Anti-Human CD314 (APC-65188, Clone:1D11) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
1X10^6 human PBMCs were surface stained with 10 ul APC Anti-Human CD314 (APC-65188, Clone:1D11) or Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
1x10^6 human PBMCs were surface stained with CL750 Anti-Human CD8 and 5 ul Atlantic Blue™ Anti-Human CD314 (AB-65188, Clone:1D11) or Atlantic Blue™ Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
1x10^6 human PBMCs were surface stained with 5 ul Atlantic Blue™ Anti-Human CD314 (AB-65188, Clone:1D11) or Atlantic Blue™ Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
1x10^6 human PBMCs were surface stained with CL750 Anti-Human CD8 and 5 ul Cardinal Red™ Anti-Human CD314 (CR-65188, Clone:1D11) or Cardinal Red™ Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
1x10^6 human PBMCs were surface stained with 5 ul Cardinal Red™ Anti-Human CD314 (CR-65188, Clone:1D11) or Cardinal Red™ Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
1x10^6 human PBMCs were surface stained with CL750 Anti-Human CD8 and 5 ul CoraLite® Plus 405 Anti-Human CD314 (CL405-65188, Clone:1D11) or CoraLite® Plus 405 Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
1x10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 405 Anti-Human CD314 (CL405-65188, Clone:1D11) or CoraLite® Plus 405 Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
1x10^6 human PBMCs were surface stained with CL750 Anti-Human CD8 and 5 ul CoraLite® Plus 488 Anti-Human CD314 (CL488-65188, Clone:1D11) or CoraLite® Plus 488 Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
1x10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 488 Anti-Human CD314 (CL488-65188, Clone:1D11) or CoraLite® Plus 488 Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
1x10^6 human PBMCs were surface stained with CL750 Anti-Human CD8 and 5 ul CoraLite® Plus 555 Anti-Human CD314 (CL555-65188, Clone:1D11) or CoraLite® Plus 555 Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
1x10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 555 Anti-Human CD314 (CL555-65188, Clone:1D11) or CoraLite® Plus 555 Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
1x10^6 human PBMCs were surface stained with CL750 Anti-Human CD8 and 5 ul CoraLite® Plus 594 Anti-Human CD314 (CL594-65188, Clone:1D11) or CoraLite® Plus 594 Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
1x10^6 human PBMCs were surface stained with 5 ul CoraLite® Plus 594 Anti-Human CD314 (CL594-65188, Clone:1D11) or CoraLite® Plus 594 Mouse IgG1 Isotype Control. Cells were not fixed. Lymphocytes were gated.
